53 (PB043) - The TBL1 inhibitor, Tegavivint, suppresses tumour growth and enhances T-cell infiltration in preclinical murine β-Catenin mutant hepatocellular carcinoma
- Resource Type
- Abstract
- Source
- In
European Journal of Cancer October 2022 174 Supplement 1:S19-S19 - Subject
- Language
- ISSN
- 0959-8049